Literature DB >> 20541676

Keratoacanthoma: facts and controversies.

Christine J Ko1.   

Abstract

The keratoacanthoma and its variants are clinically and histologically heterogenous. Some consider the keratoacanthoma to be benign, whereas others classify it as a subtype of squamous cell carcinoma. The keratoacanthoma is generally treated rather than observed for spontaneous resolution. This hampers evaluation of the true natural history of lesions diagnosed as keratoacanthoma. In addition, studies have not found a reliable marker to differentiate keratoacanthoma from squamous cell carcinoma. It currently remains unclear how the keratoacanthoma relates to squamous cell carcinoma, and continued investigation is necessary. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2010        PMID： 20541676     DOI： 10.1016/j.clindermatol.2009.06.010

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN： 0738-081X            Impact factor:   3.541


  19 in total

1.  RAS mutations are associated with the development of cutaneous squamous cell tumors in patients treated with RAF inhibitors.

Authors:  Patrick A Oberholzer; Damien Kee; Piotr Dziunycz; Antje Sucker; Nyam Kamsukom; Robert Jones; Christine Roden; Clinton J Chalk; Kristin Ardlie; Emanuele Palescandolo; Adriano Piris; Laura E MacConaill; Caroline Robert; Günther F L Hofbauer; Grant A McArthur; Dirk Schadendorf; Levi A Garraway
Journal:  J Clin Oncol       Date:  2011-11-07       Impact factor: 44.544

2.  The Role of p16, p21, p27, p53 and Ki-67 Expression in the Differential Diagnosis of Cutaneous Squamous Cell Carcinomas and Keratoacanthomas: An Immunohistochemical Study.

Authors:  Recep Bedir; Hasan Güçer; İbrahim Şehitoğlu; Cüneyt Yurdakul; Pelin Bağcı; Pelin Üstüner
Journal:  Balkan Med J       Date:  2016-03-01       Impact factor: 2.021

3.  Double localization of keratoacantho-ma on the cutaneous and mucosal sides of the lower lip: report of a case.

Authors:  M P Cristalli; R Marini; G LA Monaca; D Vitolo; G Pompa; S Annibali
Journal:  Oral Implantol (Rome)       Date:  2014-05-19

4.  Patterns of LC3A Autophagy Protein Expression in Keratoacanthomas.

Authors:  Efthimios Sivridis; Ioannis M Koukourakis; Stella Arelaki; Kostantina Balaska; Antonios Karpouzis; Alexandra Giatromanolaki
Journal:  Head Neck Pathol       Date:  2019-04-11

5.  A Giant Keratoacanthoma Treated with Surgical Excision.

Authors:  Hyochun Park; Hannara Park; Hoonnam Kim; Hyeonjung Yeo
Journal:  Arch Craniofac Surg       Date:  2015-08-11

Review 6.  CT and MRI features of scalp lesions.

Authors:  Masaya Kawaguchi; Hiroki Kato; Masayuki Matsuo
Journal:  Radiol Med       Date:  2019-07-03       Impact factor: 3.469

7.  Analysis of dermatologic events in vemurafenib-treated patients with melanoma.

Authors:  Mario E Lacouture; Madeleine Duvic; Axel Hauschild; Victor G Prieto; Caroline Robert; Dirk Schadendorf; Caroline C Kim; Christopher J McCormack; Patricia L Myskowski; Olivia Spleiss; Kerstin Trunzer; Fei Su; Betty Nelson; Keith B Nolop; Joseph F Grippo; Richard J Lee; Matthew J Klimek; James L Troy; Andrew K Joe
Journal:  Oncologist       Date:  2013-03-01

8.  CD8+ Immunosenescence Predicts Post-Transplant Cutaneous Squamous Cell Carcinoma in High-Risk Patients.

Authors:  Matthew J Bottomley; Paul N Harden; Kathryn J Wood
Journal:  J Am Soc Nephrol       Date:  2015-11-12       Impact factor: 10.121

9.  Ectopic expression of Zmiz1 induces cutaneous squamous cell malignancies in a mouse model of cancer.

Authors:  Laura M Rogers; Jesse D Riordan; Brian L Swick; David K Meyerholz; Adam J Dupuy
Journal:  J Invest Dermatol       Date:  2013-02-20       Impact factor: 8.551

10.  Use of double-bladed biopsy in distinguishing keratoacanthoma from squamous cell carcinoma-a case report.

Authors:  Keith Hopkins; Sharad Paul; David Weedon; Cliff Rosendahl
Journal:  Dermatol Pract Concept       Date:  2013-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.